These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 37466356)
1. Omics markers of platelet transfusion in trauma patients. LaCroix IS; Cohen M; Moore EE; Dzieciatkowska M; Silliman CC; Hansen KC; D'Alessandro A Transfusion; 2023 Aug; 63(8):1447-1462. PubMed ID: 37466356 [TBL] [Abstract][Full Text] [Related]
2. Omics Markers of Red Blood Cell Transfusion in Trauma. LaCroix IS; Cohen M; Moore EE; Dzieciatkowska M; Nemkov T; Schaid TR; Debot M; Jones K; Silliman CC; Hansen KC; D'Alessandro A Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430297 [TBL] [Abstract][Full Text] [Related]
3. Pathogen-reduced platelets for the prevention of bleeding. Butler C; Doree C; Estcourt LJ; Trivella M; Hopewell S; Brunskill SJ; Stanworth S; Murphy MF Cochrane Database Syst Rev; 2013 Mar; (3):CD009072. PubMed ID: 23543569 [TBL] [Abstract][Full Text] [Related]
4. Platelet transfusions reduce fibrinolysis but do not restore platelet function during trauma hemorrhage. Vulliamy P; Gillespie S; Gall LS; Green L; Brohi K; Davenport RA J Trauma Acute Care Surg; 2017 Sep; 83(3):388-397. PubMed ID: 28452886 [TBL] [Abstract][Full Text] [Related]
5. Ten-year analysis of transfusion in Operation Iraqi Freedom and Operation Enduring Freedom: increased plasma and platelet use correlates with improved survival. Pidcoke HF; Aden JK; Mora AG; Borgman MA; Spinella PC; Dubick MA; Blackbourne LH; Cap AP J Trauma Acute Care Surg; 2012 Dec; 73(6 Suppl 5):S445-52. PubMed ID: 23192068 [TBL] [Abstract][Full Text] [Related]
6. Debunking the survival bias myth: characterization of mortality during the initial 24 hours for patients requiring massive transfusion. Brown JB; Cohen MJ; Minei JP; Maier RV; West MA; Billiar TR; Peitzman AB; Moore EE; Cushieri J; Sperry JL; J Trauma Acute Care Surg; 2012 Aug; 73(2):358-64; discussion 364. PubMed ID: 22846940 [TBL] [Abstract][Full Text] [Related]
7. Effect of platelet storage duration on clinical outcomes and incremental platelet change in critically ill children. Nellis ME; Spinella PC; Tucci M; Stanworth SJ; Steiner ME; Cushing MM; Davis PJ; Karam O; Transfusion; 2020 Dec; 60(12):2849-2858. PubMed ID: 32959409 [TBL] [Abstract][Full Text] [Related]
8. Severely injured trauma patients with admission hyperfibrinolysis: Is there a role of tranexamic acid? Findings from the PROPPR trial. Khan M; Jehan F; Bulger EM; OʼKeeffe T; Holcomb JB; Wade CE; Schreiber MA; Joseph B; J Trauma Acute Care Surg; 2018 Nov; 85(5):851-857. PubMed ID: 29985230 [TBL] [Abstract][Full Text] [Related]
9. Changes in massive transfusion over time: an early shift in the right direction? Kautza BC; Cohen MJ; Cuschieri J; Minei JP; Brackenridge SC; Maier RV; Harbrecht BG; Moore EE; Billiar TR; Peitzman AB; Sperry JL; J Trauma Acute Care Surg; 2012 Jan; 72(1):106-11. PubMed ID: 22310123 [TBL] [Abstract][Full Text] [Related]
10. Platelet dose consistency and its effect on the number of platelet transfusions for support of thrombocytopenia: an analysis of the SPRINT trial of platelets photochemically treated with amotosalen HCl and ultraviolet A light. Murphy S; Snyder E; Cable R; Slichter SJ; Strauss RG; McCullough J; Lin JS; Corash L; Conlan MG; Transfusion; 2006 Jan; 46(1):24-33. PubMed ID: 16398727 [TBL] [Abstract][Full Text] [Related]
11. Platelet Transfusion and Outcomes After Massive Transfusion Protocol Activation for Major Trauma: A Retrospective Cohort Study. Aichholz PK; Lee SA; Farr CK; Tsang HC; Vavilala MS; Stansbury LG; Hess JR Anesth Analg; 2022 Aug; 135(2):385-393. PubMed ID: 35522847 [TBL] [Abstract][Full Text] [Related]
12. Critical issues in hematology: anemia, thrombocytopenia, coagulopathy, and blood product transfusions in critically ill patients. Drews RE Clin Chest Med; 2003 Dec; 24(4):607-22. PubMed ID: 14710693 [TBL] [Abstract][Full Text] [Related]
13. Platelet storage duration and its clinical and transfusion outcomes: a systematic review. Aubron C; Flint AWJ; Ozier Y; McQuilten Z Crit Care; 2018 Aug; 22(1):185. PubMed ID: 30077181 [TBL] [Abstract][Full Text] [Related]
14. Antifibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological disorders. Wardrop D; Estcourt LJ; Brunskill SJ; Doree C; Trivella M; Stanworth S; Murphy MF Cochrane Database Syst Rev; 2013 Jul; (7):CD009733. PubMed ID: 23897323 [TBL] [Abstract][Full Text] [Related]
15. Therapeutic efficacy of platelet transfusion treated with amotosalen/UVA pathogen inactivation technology (INTERCEPT Ladaique P; Etienne JM; Pedini P; Chiaroni J; Vey N; Picard C; Chabrieres C Blood Transfus; 2023 Sep; 21(5):400-408. PubMed ID: 36795348 [TBL] [Abstract][Full Text] [Related]
16. High ratio plasma resuscitation does not improve survival in pediatric trauma patients. Cannon JW; Johnson MA; Caskey RC; Borgman MA; Neff LP J Trauma Acute Care Surg; 2017 Aug; 83(2):211-217. PubMed ID: 28481839 [TBL] [Abstract][Full Text] [Related]
17. The clinical significance of platelet counts in the first 24 hours after severe injury. Stansbury LG; Hess AS; Thompson K; Kramer B; Scalea TM; Hess JR Transfusion; 2013 Apr; 53(4):783-9. PubMed ID: 22882316 [TBL] [Abstract][Full Text] [Related]
18. Transfusion and hematologic variables after fibrinogen or platelet transfusion in valve replacement surgery: preliminary data of purified lyophilized human fibrinogen concentrate versus conventional transfusion. Tanaka KA; Egan K; Szlam F; Ogawa S; Roback JD; Sreeram G; Guyton RA; Chen EP Transfusion; 2014 Jan; 54(1):109-18. PubMed ID: 23718572 [TBL] [Abstract][Full Text] [Related]
19. Patient and product factors affecting platelet transfusion results. Heim D; Passweg J; Gregor M; Buser A; Theocharides A; Arber C; Meyer-Monard S; Halter J; Tichelli A; Gratwohl A Transfusion; 2008 Apr; 48(4):681-7. PubMed ID: 18208413 [TBL] [Abstract][Full Text] [Related]